Matinas BioPharma Commences Dosing in First Human Trial of Lead Product Candidate MAT9001
November 12, 2014 07:35 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas Biopharma Receives Notice of Allowance of U.S. Patent for MAT9001
November 10, 2014 07:35 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma Appoints Cardiologist and Lipidology Expert Christie M. Ballantyne, M.D. to Scientific Advisory Board
November 04, 2014 07:35 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma Receives Authorization From Health Canada to Initiate Human Clinical Study of Lead Product Candidate MAT9001
October 29, 2014 07:35 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma Submits Investigational New Drug Application for Lead Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia
October 20, 2014 08:05 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Oct. 20, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma to Present at the 13th Annual BIO Investor Forum on Wednesday, October 8, 2014
September 30, 2014 07:35 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma Holdings, Inc. Approved to Trade on OTCQB Venture Stage Marketplace
September 08, 2014 07:05 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), an emerging biopharmaceutical company focused on the...
Matinas BioPharma to Present at Three Investor Conferences in September
September 04, 2014 07:05 ET
|
Matinas BioPharma Holdings, Inc.
- Rodman & Renshaw 16th Annual Global Investment Presentation and Live Audio Webcast on September 9, 2014 -
- SeeThruEquity Fall Microcap Presentation on September 11, 2014 -
- Aegis...
Matinas BioPharma Launches Digital Corporate Communication Channels
July 31, 2014 08:05 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., July 31, 2014 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCBB:MTNB), an emerging biopharmaceutical company focused on the...